Log in
Enquire now
‌

US Patent 11236052 Aminobenzimidazole derivatives, treatments, and methods of inhibiting histone deacetylase

Patent 11236052 was granted and assigned to Translational Drug Development (Td2) on February, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Patent abstract

The present invention is directed to novel aminobenzimidazole derivatives. The present invention is also directed to methods of treating a histone deacetylase (HDAC)-associated disease or inhibiting the histone deacetylating activity of a HDAC isoform in a cell or with one or more of the aminobenzimidazole derivatives.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11236052 Aminobenzimidazole derivatives, treatments, and methods of inhibiting histone deacetylase

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo